Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

News In Brief

This article was originally published in The Gray Sheet

Executive Summary

Teleflex buys Hotspur, unloads OEM ortho unit. Life Technologies snaps up Navigenics. Accuray acquires Morphormics. More news briefs.

You may also be interested in...



Teleflex To Dominate Laryngeal Mask Market Following $276 Mil. LMA Buy

LMA International, which controls 85% of the global market for laryngeal masks, will complement Teleflex’s existing anesthesia and respiratory businesses. The masks support the airway of patients undergoing surgical procedures and other life-saving interventions.

News in Brief

Hill-Rom buys Aspen Surgical for $400 million. Life Technologies obtains lung cancer prognostic test. More news briefs.

Device Tax Repeal As Tax Reform: AdvaMed Makes The Case

AdvaMed aims to “decouple” discussion of the device tax from the health care reform debate and link its repeal to broader efforts focused on improving the U.S. tax system.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT031412

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel